State Street Corp Vanda Pharmaceuticals Inc. Transaction History

State Street Corp

$2.59 Trillion
Q2 2025

A detailed history of State Street Corp transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, State Street Corp holds 1,265,847 shares of VNDA stock, worth $5.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,265,847

Previous 1,252,559 1.06%

Holding current value

$5.54 Million

Previous $5.75 Million 3.91%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$3.92 - $4.82 $52,088 - $64,048	13,288 Added 1.06%	1,265,847 $5.97 Million
Q1 2025 May 15, 2025	BUY	$4.31 - $5.13 $296,079 - $352,410	68,696 Added 5.8%	1,252,559 $5.75 Million
Q4 2024 Feb 14, 2025	BUY	$4.41 - $5.46 $82,383 - $101,998	18,681 Added 1.6%	1,183,863 $5.67 Million
Q3 2024 Nov 14, 2024	SELL	$4.61 - $6.34 $212,645 - $292,445	-46,127 Reduced 3.81%	1,165,182 $5.46 Million
Q2 2024 Aug 14, 2024	BUY	$3.91 - $6.5 $31,334 - $52,091	8,014 Added 0.67%	1,211,309 $6.84 Million
Q1 2024 May 15, 2024	SELL	$3.47 - $4.61 $86,059 - $114,332	-24,801 Reduced 2.02%	1,203,295 $4.95 Million
Q4 2023 Feb 14, 2024	SELL	$3.38 - $4.58 $255,815 - $346,637	-75,685 Reduced 5.81%	1,228,096 $5.18 Million
Q3 2023 Nov 14, 2023	SELL	$4.28 - $6.57 $11.9 Million - $18.2 Million	-2,776,855 Reduced 68.05%	1,303,781 $5.63 Million
Q2 2023 Aug 14, 2023	SELL	$5.9 - $6.95 $2.78 Million - $3.28 Million	-471,276 Reduced 10.35%	4,080,636 $26.9 Million
Q1 2023 May 15, 2023	BUY	$6.18 - $7.99 $5.09 Million - $6.58 Million	824,114 Added 22.11%	4,551,912 $30.9 Million
Q4 2022 Feb 14, 2023	BUY	$6.87 - $10.96 $291,610 - $465,219	42,447 Added 1.15%	3,727,798 $27.5 Million
Q3 2022 Nov 15, 2022	SELL	$9.44 - $11.76 $288,618 - $359,550	-30,574 Reduced 0.82%	3,685,351 $36.4 Million
Q2 2022 Aug 15, 2022	SELL	$9.31 - $11.84 $3.23 Million - $4.11 Million	-347,373 Reduced 8.55%	3,715,925 $40.5 Million
Q1 2022 May 16, 2022	BUY	$10.84 - $16.55 $7.98 Million - $12.2 Million	735,865 Added 22.12%	4,063,298 $46 Million
Q4 2021 Feb 14, 2022	SELL	$15.69 - $21.14 $1.11 Million - $1.49 Million	-70,609 Reduced 2.08%	3,327,433 $52.2 Million
Q3 2021 Nov 15, 2021	BUY	$15.35 - $21.27 $3.63 Million - $5.03 Million	236,533 Added 7.48%	3,398,042 $58.2 Million
Q2 2021 Aug 16, 2021	SELL	$15.71 - $21.51 $2.37 Million - $3.24 Million	-150,830 Reduced 4.55%	3,161,509 $68 Million
Q1 2021 May 17, 2021	BUY	$13.42 - $20.28 $1.46 Million - $2.2 Million	108,435 Added 3.38%	3,312,339 $49.8 Million
Q4 2020 Feb 16, 2021	SELL	$9.77 - $13.81 $1.77 Million - $2.51 Million	-181,430 Reduced 5.36%	3,203,904 $42.1 Million
Q3 2020 Nov 10, 2020	SELL	$9.32 - $12.02 $2.73 Million - $3.53 Million	-293,278 Reduced 7.97%	3,385,334 $32.7 Million
Q2 2020 Aug 14, 2020	BUY	$9.66 - $12.02 $8.14 Million - $10.1 Million	842,696 Added 29.72%	3,678,612 $42.1 Million
Q1 2020 May 11, 2020	BUY	$7.5 - $16.8 $21.3 Million - $47.6 Million	2,835,916 New	2,835,916 $29.4 Million

Others Institutions Holding VNDA

# of Institutions

151

Shares Held

45.4M

Call Options Held

20K

Put Options Held

999K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $248M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Vanda Pharmaceuticals Inc. Transaction History